These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Arad G; Levy R; Hillman D; Kaempfer R Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148 [TBL] [Abstract][Full Text] [Related]
4. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Arad G; Hillman D; Levy R; Kaempfer R Immunol Lett; 2004 Feb; 91(2-3):141-5. PubMed ID: 15019282 [TBL] [Abstract][Full Text] [Related]
5. The bacterial superantigen and superantigen-like proteins. Fraser JD; Proft T Immunol Rev; 2008 Oct; 225():226-43. PubMed ID: 18837785 [TBL] [Abstract][Full Text] [Related]
6. Animal Models Used to Study Superantigen-Mediated Diseases. Brosnahan AJ Methods Mol Biol; 2016; 1396():1-17. PubMed ID: 26676033 [TBL] [Abstract][Full Text] [Related]
7. Defense against biologic warfare with superantigen toxins. Kaempfer R; Arad G; Levy R; Hillman D Isr Med Assoc J; 2002 Jul; 4(7):520-3. PubMed ID: 12120463 [TBL] [Abstract][Full Text] [Related]
11. Streptococcus pyogenes: Insight into the function of the streptococcal superantigens. Sriskandan S; Faulkner L; Hopkins P Int J Biochem Cell Biol; 2007; 39(1):12-9. PubMed ID: 17029999 [TBL] [Abstract][Full Text] [Related]
12. Superantigens and pseudosuperantigens of gram-positive cocci. Fleischer B; Gerlach D; Fuhrmann A; Schmidt KH Med Microbiol Immunol; 1995 May; 184(1):1-8. PubMed ID: 8538573 [TBL] [Abstract][Full Text] [Related]
13. Toxoids of streptococcal pyrogenic exotoxin A are protective in rabbit models of streptococcal toxic shock syndrome. Roggiani M; Stoehr JA; Olmsted SB; Matsuka YV; Pillai S; Ohlendorf DH; Schlievert PM Infect Immun; 2000 Sep; 68(9):5011-7. PubMed ID: 10948118 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of bacterial superantigens by peptides and antibodies. Visvanathan K; Charles A; Bannan J; Pugach P; Kashfi K; Zabriskie JB Infect Immun; 2001 Feb; 69(2):875-84. PubMed ID: 11159981 [TBL] [Abstract][Full Text] [Related]
16. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Bannan J; Visvanathan K; Zabriskie JB Infect Dis Clin North Am; 1999 Jun; 13(2):387-96, ix. PubMed ID: 10340173 [TBL] [Abstract][Full Text] [Related]
17. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome. Sriskandan S; Moyes D; Cohen J Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404 [No Abstract] [Full Text] [Related]
18. Microbial superantigens as virulence factors and ways to counteract their actions. Tarkowski A; Collins LV; Jonsson IM; Eriksson K; Sakiniene E; Verdrengh M Scand J Infect Dis; 2003; 35(9):642-6. PubMed ID: 14620148 [TBL] [Abstract][Full Text] [Related]